Zofran Plaintiffs Say GSK Hid FDA Lobbying From Discovery
Citing what GlaxoSmithKline attorneys have called "some crazy conspiracy theory," plaintiffs claimed Wednesday that GSK hid from discovery its efforts to lobby the U.S. Food and Drug Administration about the multidistrict...To view the full article, register now.
Already a subscriber? Click here to view full article